东星医疗
(301290)
| 流通市值：16.82亿 | | | 总市值：24.72亿 |
| 流通股本：6816.38万 | | | 总股本：1.00亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 78,186,465.07 | 435,463,080.43 | 316,018,608.17 | 213,553,049.86 |
| 营业收入 | 78,186,465.07 | 435,463,080.43 | 316,018,608.17 | 213,553,049.86 |
| 二、营业总成本 | 72,372,834.27 | 358,927,111.5 | 265,917,172.26 | 178,057,565.42 |
| 营业成本 | 43,469,650.62 | 220,492,163.52 | 161,890,589.14 | 111,536,743.85 |
| 税金及附加 | 1,060,168.71 | 5,179,633.04 | 3,639,239.43 | 2,238,569.62 |
| 销售费用 | 8,190,354.26 | 47,576,239.82 | 35,597,739.13 | 22,621,178.59 |
| 管理费用 | 15,240,570.06 | 65,369,542.32 | 50,851,498.2 | 34,648,528.09 |
| 研发费用 | 4,169,622.11 | 22,433,892.09 | 16,698,408.37 | 9,723,871.09 |
| 财务费用 | 242,468.51 | -2,124,359.29 | -2,760,302.01 | -2,711,325.82 |
| 其中:利息费用 | 176,906.96 | 338,527.01 | 197,135.61 | 111,356.52 |
| 其中:利息收入 | 115,402.24 | 2,699,802.9 | 3,226,149.73 | 2,950,298.69 |
| 加:公允价值变动收益 | 107,681.68 | -7,000,940.2 | -7,315,799.69 | -4,461,677.91 |
| 加:投资收益 | 6,486,358.28 | 36,695,547.36 | 27,765,340.17 | 18,250,206.02 |
| 资产处置收益 | -356.13 | -83,679.38 | -33,857.52 | -33,857.52 |
| 资产减值损失(新) | -29,647 | -480,308.03 | 330,429.41 | 138,752.51 |
| 信用减值损失(新) | 1,018,541.47 | -246,809.35 | -1,408,241.48 | -415,458.83 |
| 其他收益 | 904,710.09 | 10,222,971.26 | 9,201,243.22 | 8,300,348.24 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 14,300,919.19 | 115,642,750.59 | 78,640,550.02 | 57,273,796.95 |
| 加:营业外收入 | 18,845.23 | 177,247.22 | 83,145.96 | 54,082.37 |
| 减:营业外支出 | 17,632.78 | 756,936.75 | 710,214.44 | 685,398.23 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 14,302,131.64 | 115,063,061.06 | 78,013,481.54 | 56,642,481.09 |
| 减:所得税费用 | 2,628,534.54 | 18,171,882.27 | 12,566,902.08 | 9,184,264.99 |
| 六、净利润 | 11,673,597.1 | 96,891,178.79 | 65,446,579.46 | 47,458,216.1 |
| 持续经营净利润 | 11,673,597.1 | 96,891,178.79 | 65,446,579.46 | 47,458,216.1 |
| 归属于母公司股东的净利润 | 12,063,975.22 | 97,424,753.19 | 65,578,456.4 | 47,679,809.37 |
| 少数股东损益 | -390,378.12 | -533,574.4 | -131,876.94 | -221,593.27 |
| (一)基本每股收益 | 0.12 | 0.98 | 0.66 | 0.48 |
| (二)稀释每股收益 | 0.12 | 0.98 | 0.66 | 0.48 |
| 九、综合收益总额 | 11,673,597.1 | 96,891,178.79 | 65,446,579.46 | 47,458,216.1 |
| 归属于母公司股东的综合收益总额 | 12,063,975.22 | 97,424,753.19 | 65,578,456.4 | 47,679,809.37 |
| 归属于少数股东的综合收益总额 | -390,378.12 | -533,574.4 | -131,876.94 | -221,593.27 |
| 公告日期 | 2025-04-25 | 2025-04-15 | 2024-10-25 | 2024-08-16 |
| 审计意见(境内) | | 标准无保留意见 | | |